Christina Mattina

Christina Mattina

Christina is the associate editorial director of The American Journal of Managed Care® (AJMC®) and Population Health, Equity & Outcomes, and joined AJMC in 2016. She oversees the publication of the print journals, from manuscript submission to publication, and works with the editors in chief and editorial boards to promote the journals.

She has a BS in public health from Rutgers University. You can connect with Christina on LinkedIn.

Articles by Christina Mattina

After widespread criticism from healthcare providers, drug companies, and lawmakers, CMS has announced that it will not go forward with its proposed Medicare Part B payment program. The experimental reimbursement model was intended to reduce outpatient drug spending, but oncologists worried it would have unfairly slashed their Part B payments.

A recently released report investigates the potential ramifications of partially repealing the Affordable Care Act through the process of budget reconciliation. The study by the Urban Institute Health Policy Center warned that such a move by Congress would double the number of uninsured Americans and significantly disrupt the insurance market, resulting in reduced access to care.

The amount of Americans under age 65 in families having trouble paying medical bills has dropped significantly over the past 5 years, according to a survey report from the National Center for Health Statistics. The percentage of children in families that struggle to pay healthcare bills has steadily declined as well, though as of June 2016 it remained higher than the percentage of such adults.

The 5th annual Patient-Centered Oncology Care® (PCOC) meeting, hosted by The American Journal of Managed Care, November 17-18, in Baltimore, Maryland, concluded with a panel discussion on the future of oncology care in 2017. The panelists concurred that value-based payment is here to stay despite the imminent changes in healthcare.

A study of older Americans has found that the prevalence of dementia has decreased significantly, from 11.6% in 2000 to 8.8% in 2012. It cited increased average educational attainment and improved diabetes treatments as factors that could explain the drop in dementia rates.

Federal prosecutors announced in a press conference that Gary Tanner, a former executive at Valeant Pharmaceuticals, and Andrew Davenport, former chief executive officer of Philidor Rx Services, had been charged with taking part in a multimillion-dollar fraud and kickback scheme.